Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|February 3, 2022
Probing the Requirements for Dual Angiotensin-Converting Enzyme C-Domain Selective/Neprilysin InhibitionLauren B Arendse, Gyles E Cozier, Charles J Eyermann, et al.
Journal of Medicinal Chemistry|April 1, 2025
Design of Novel Mercapto-3-phenylpropanoyl Dipeptides as Dual Angiotensin-Converting Enzyme C-Domain-Selective/Neprilysin InhibitorsGyles E Cozier, Lauren B Coulson, Charles J Eyermann, et al.
Pharmacological Reviews|September 30, 2022
The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic TargetU Muscha Steckelings, Robert E Widdop, Edward D Sturrock, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 5, 2013
Association of B2 receptor polymorphisms and ACE activity with ACE inhibitor-induced angioedema in black and mixed-race South AfricansRetsilisitsoe R Moholisa, Brian R Rayner, E Patricia Owen, et al.
Pharmacological Reviews|September 21, 2019
Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart FailureLauren B Arendse, A H Jan Danser, Marko Poglitsch, et al.
Biological Chemistry|August 10, 2006
Homologous substitution of ACE C-domain regions with N-domain sequences: effect on processing, shedding, and catalytic propertiesZenda L Woodman, Sylva L U Schwager, Pierre Redelinghuys, et al.
Biological Chemistry|June 3, 2006
Angiotensin I-converting enzyme inhibitor peptides derived from the endostatin-containing NC1 fragment of human collagen XVIIIShirley L Farias, Regiane A Sabatini, Tatiana C Sampaio, et al.
Pageof 10